Diets · Metabolic & Cardiometabolic
ketogenic diet improves glycemic control
In plain terms: Does a keto diet improve blood-sugar control in diabetes?
Part of: 🥗 ketogenic diet
Yes, in the short term, but the benefit fades over time as the diet gets harder to stick to.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Ketogenic/low-carb diets improve glycemic control and HbA1c in T2D in the short term (strongest at <=6 months); the benefit attenuates with time as adherence erodes.
The evidence (16)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jönsson T, Beardsley J, Johnson JA, Thabane L, Johnston BC 2021 · BMJ | meta-analysis | supports | moderate | MA 23 RCTs: at 6mo LCD raised remission (RD 0.32) + improved HbA1c/weight/TG |
| Parry-Strong A, Wright-McNaughton M, Weatherall M, Hall RM, Coppell KJ, Barthow C, Krebs JD 2022 · Diabetes Obes Metab | meta-analysis | mixed | moderate | Meta-analysis of RCTs: very-low-carb (ketogenic) diets improved glycemic control in type 2 diabetes, mainly in the short term. |
| Mongkolsucharitkul P, Surawit A, Pimsen A, Winitchayothin S, Pumeiam S, Pinsawas B, Ophakas S, Suta S, Pasookhush P, Mayurasakorn K 2025 · Diabetes Res Clin Pract | meta-analysis | supports | moderate | Meta-analysis: low-carbohydrate diets improved T2D glycemic outcomes across Eastern and Western populations, with magnitude varying by population. |
| Liu H, Wu W, He N, Wang X, Pan S, Zhu L, Ma S, Zhang Y, Liu Z 2026 · BMC cardiovascular disorders | meta-analysis | supports | moderate | 24 studies (20 RCTs), >47,000 adults: KD improved fasting glucose and HbA1c vs control diets (no pooled MD given in abstract) |
| Jayedi A, Zeraattalab-Motlagh S, Jabbarzadeh B, Hosseini Y, Jibril AT, Shahinfar H, Mirrafiei A, Hosseini F, Bidar SS 2022 · Am J Clin Nutr | meta-analysis | supports | high | Dose-response meta-analysis: greater carbohydrate restriction produced larger short-term HbA1c reductions in type 2 diabetes; effect attenuated by 12 months. |
| Saslow LR, Daubenmier JJ, Moskowitz JT, Kim S, Murphy EJ, Phinney SD, Ploutz-Snyder R, Goldman V, Cox RM, Mason AE, Moran P, Hecht FM 2017 · Nutrition & Diabetes | RCT | supports | low | 12-month RCT: very-low-carb diet vs moderate-carb improved HbA1c and reduced diabetes medications in overweight T2D/prediabetes adults. |
| Jing T, Zhang S, Bai M, Chen Z, Gao S, Li S, Zhang J 2023 · Nutrients | meta-analysis | supports | high | Network meta-analysis of dietary approaches: low-carbohydrate/ketogenic patterns ranked among the most effective for glycemic control in T2D. |
| Beretta MV, Flores CAO, Colameo GF, Echabe LW, Busnello FM 2025 · Nutrition Reviews | meta-analysis | mixed | moderate | Overview of systematic reviews (units: 'Systematic reviews with meta-analysis of randomized clinical trials'): LC diets vs control, HbA1c '-0.42 (-1.45 to -0.09; high certainty of evidence)'; up to 3 mo -0.28, 6-12 mo -0.32 (-0.49 to 0.11). Exposure is low-carb broadly, not keto. Re-passes syntheses — review, zero weight. |
| Ichikawa T, Okada H, Hironaka J, Nakajima H, Okamura T, Majima S, Senmaru T, Ushigome E, Nakanishi N, Hamaguchi M, Joo E, Shide K, Fukui M 2024 · J Diabetes Investig | meta-analysis | contradicts | moderate | Meta-analysis: long-term low-carb diets showed NO significant HbA1c benefit vs control in T2D; durable glycemic advantage not supported. |
| Khraise Y 2026 · Cureus | meta-analysis | supports | low | MA 7 RCTs n=562: HbA1c -0.24% (modest, clean) |
| Gardner CD, Landry MJ, Perelman D, Petlura C, Durand LR, Aronica L, Crimarco A, Cunanan KM, Chang A, Dant CC, Robinson JL, Kim SH 2022 · Am J Clin Nutr | RCT | mixed | high | Keto-Med crossover: HbA1c did NOT differ between ketogenic and Mediterranean diet at 12 weeks; glycemic benefit attributable to carb reduction, not ketosis per se. |
| Oliveira BF, Chang CR, Oetsch K, Falkenhain K, Crampton K, Stork M, Hoonjan M, Elliott T, Francois ME, Little JP 2023 · Am J Clin Nutr | RCT | supports | moderate | Low-carbohydrate vs low-fat breakfast improved postprandial and overall blood-glucose control in type 2 diabetes in a randomized trial. |
| Choi YJ, Jeon SM, Shin S 2020 · Nutrients | meta-analysis | supports | moderate | Meta-analysis of RCTs: ketogenic diets improved glycemic and metabolic parameters in patients with obesity/overweight, with/without T2D. |
| Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, Hong D, Tian S, Sun C 2020 · Nutr Diabetes | meta-analysis | supports | low | SR/MA: KD improved glycemic control & insulin sensitivity vs control in T2D |
| Barrionuevo-Burgos E, García-García RM, Muñoz L, Arreguín-Coronado A 2026 · Nutrition and health | RCT | supports | low | 12wk, T2D, n=30 (IF+KD, HD, control): HbA1c decreased in both IF+KD and HD groups (p<0.05); non-randomized controlled design |
| Rafiullah M, Musambil M, David SK 2022 · Nutrition Reviews | meta-analysis | supports | moderate | Meta-analysis: VLCKD vs recommended diets lowered HbA1c and improved glycemic measures in type 2 diabetes over the studied intervals. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.